APIS Health Angels Logo
For Investors
For Startups
Events & Workshops
About Us
Resources
Account options (Coming Soon)
My Account (coming soon)
Connect with us
Account options (Coming Soon)
My Account (coming soon)
Connect with us
Account options (Coming Soon)
My Account (coming soon)
Connect with us
Account options (Coming Soon)
My Account (coming soon)
Connect with us
Account options (Coming Soon)
My Account (coming soon)
Connect with us

Blog

May 3, 2022
Conducting Better Experiments

This workshop describes how to conduct better experiments to assist you in market research. https://www.meetup.com/Seattle-Angel/events/285666213/

Read More
April 8, 2022
Inaugural Cohort One Announces Investment Winner Dr. Greg Grover and Karios Technologies

With an innovative adhesion prevention treatment goal, Karios Technologies wins the Apis Health Angels Conference.

Read More
March 12, 2022
Apis Health Angels Announces MC

Apis Health Angels announces our Final Demo MC.

Read More
March 12, 2022
Apis Health Angels Announces Our Finalists

Apis Health Angel Investors Make their Finalist Selections.

Read More
February 28, 2022
Quarter Finalist Night Two!

We had an amazing night two of Quarter Finalist companies. 11 founders pitched their ideas in a 3-minute slide show. These are impressive founders all solving important health problems. They wake up and think creatively!

Read More
February 28, 2022
Quarter Finalists Night One!

We were thrilled to hear from 13 of our 24 quarter finalists at a 3 minute pitch, 3 minutes of questions, and open mingle for several hours.

Read More
February 28, 2022
Semi-Finalists! Congratulations to the founders!

Announcing the 12 companies that have made it to our Apis Health Angels Semi Finals! These 12 teams have demonstrated an ability to convince the investors that their ideas are sound, that they have begun to sort out their product customer fit, maybe thought a little about their go-to-market strategies, and speculated on a business model that appears suitable to their solution.

Read More
January 24, 2022
Get Started Investing in Early-stage Companies – Learn by Doing

The best way to start early stage investing is to learn by doing. The Apis Health Angel Conference is built for just that.

Read More
January 24, 2022
Health Industry Specific Training Speeds Comfort

Our Fall Program included topics in the following areas. Investing: Health Angel Investing is unique with the opportunity for financial returns and societal impact.
Maren Nelson talked about being an angel investor and what key things she looks for in an investor pitch. Ky Calder moderated a great panel discussion with Caitlin Cameron, Susan Preston and Christiana DelloRusso, PhD to share thoughts on being an angel investor. David Giarracco helped us understand the different models for determining Health Company Valuations. Business Models can have a big influence on outcomes shared by Harold Wodlinger. Payment and Value-Based Decision Making: Julie Panek-Anderson spoke about Who Influences the Health System; Chris Saxman talked about who actually pays for health (or really an illness system). Craig Solid talked about how to look at Value Based Decision Making and ROI. Development Process: Laura Jantos stressed the importance of Patient Engagement. Caitlin Morse highlighted aligning on the risk, activities, cost and timeline or a solid foundation in the investor/founder partnership. Scott Thielman spoke about how Investors should evaluate claims of founders for product development status. Jane Lee Choe explained the digital health stack. Regulatory and Intellectual Property: Michelle Lott reinforced that while the FDA is a big deal, it is also part of a strategic advantage, particularly evaluating the different potential pathways and the costs and timeframes for each. Ryan Buckmaster provided methods to protect your intellectual property. Curated Resources: NIH Seed Lead Chris Sasiela and Investor in Residence Stephen Flaim discussed the Seed Program which evaluates good ideas, supports founders in commercializing the ideas, and then showcases this amazing curated company pool to investors. These sessions are viewable on YouTubeApisHealthAngels

Read More
January 24, 2022
Recruiting Investors and Companies

The Apis Health Angel Conference is held semi-annually, with an early year session that runs January to mid-March and a second session still to be determined. During the 11-week program expect 5-10 hours of activity per week including a 2-3 hour Thursday evening session. Each Apis cohort is preceded by a series of optional, virtual workshops hosted on the Innovation in Health Eventbrite page. These workshops provide background on specific topics related to investing and entrepreneurship in health. In addition, the Apis Health Angels investors can join the more general education sessions which are hosted at the Seattle_Angel meetup group. The cost of the program includes two components: A program registration fee of $1000, and an investment of $5000. The program registration fee supports Apis Health Angel program costs, while the investment funds are pooled from all investors and awarded to the winning company via an LLC created for this singular purpose. We are currently reserving slots for Apis Health Angels 2, which starts mid 2022. Each cohort has a limited number of investor slots. These typically fill up fast, so don’t delay. Contact Elizabeth Cross Nichol, Apis Health Angels Program Manager to schedule a call to answer your questions, and provide further details for accredited investors interested in enrolling. ‍

Read More
January 24, 2022
While Apis Health Angels is new, our sector-agnostic Seattle Angel Conference has had a number of health winners.

Apis Health Angels benefits from the SAC alumni.

Read More
December 20, 2021
AbterraBio -- An Ongoing Success Story

Seattle Angel Conference 19 grand prize winning startup company Abterra Bio.

Read More
December 16, 2021
Due Diligence for Early Stage Startups by Acacia Lawrie and Allen Nieman

Early stage start up investing requires due diligence on behalf of the investor and the founder.

Read More
December 15, 2021
Understanding Investing in Health Startups

We are excited to see that there are two health-type startup companies Brainspace Medical and Violett in the finals of SAC 20. These are just the most recent of the health companies that have participated in the Seattle Angel Conference. Other companies have been Abterra Biosciences (SAC19 winner), TENZR (SAC 15 winner), Conquer Experience (SAC IV), Alertive now Carbon Health (SAC XIII winner), Curi-bio (SAC XIII winner). With the increasing interest in the health life sciences sectors more companies are developing solutions and more individuals are wanting to participate in funding these solutions. Our goal is to make a stronger health lifesciences ecosystem focused on more informed investors and more investable startups. We have created Apis Health Angels, a health/life sciences sector-specific angel conference to accomplish this. The program has two components; skill building and investment.I

Read More
December 15, 2021
Understanding the Emotions of a Pitch!

Understanding the Pitch Process is important for founders and for investors.

Read More
December 4, 2021
Winner of SAC 20 was Health Startup BrainSpace

We are excited to see the progress that Caitlin Morse and BrainSpace will make with the $200K investment from the SAC 20 Investors.

Read More
May 5, 2021
Why I chose Angel investing in the PNW with Apis Health Angels

APIS Health Angels are part of the solution to engage the health ecosystem for funding and development.

Read More
April 2, 2021
APIS Health Angels Launched at LSINW

APIS Health Angels Launched: Growing Angel Investors + Funding Health Startups.

Read More
March 31, 2021
From zero to 60

Michelle has been doing Quality Assurance and Regulatory Affairs for over 20 years. She knows that as a startup founder and an investor you need to know where to put your efforts so that you are focusing on the important stuff. She will take you from 0 to 60 determining a startups' regulatory pathway and first quality system and submission. She also does remediation services for large companies. Serving a four-year term on the FDA Device Good Manufacturing Practices Advisory Committee (DGMP) as an advisor she reviewed feasibility and reasonableness, recommending proposed good manufacturing practice regulations in manufacturing, packing, storing, and installing devices. She was formerly an expert witness in forensic toxicology at the Mississippi Crime Laboratory. Michelle knows how to assess whether a company or an acquisition target’s RAQA issues should scuttle the deal!

Read More
March 30, 2021
Medical and Health Investing

The time is ripe for APIS -- a group focused on medical and health startups and the people who want to support them.

Read More
Follow us on social media:
Sign up for our newsletter
Copyright © 2022 Mossy Ventures
Website Development and SEO by Symphysis